← Back to Patent Explorer
US3917600A Expired / Lapsed US ⏱️ 0.0 years remaining

2-(Benzofuran)-acetamidines

Assignee: Labaz SA
•
Filing: 1973-04-23
•
Granted: 1975-11-04
•
Expires: 1993-04-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-(2-Alkyl-3-benzofuranyl)-N,N-(3-alkyl-3-azapentamethylene)acetamidines and related derivatives are useful antihypertensive agents.

Inventors

  • 👤 Marcel Descamps
  • 👤 Alex Areschka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:46
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/79; C07D405/00; C07D405/02; C07D405/12

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 5 words
A COMPOUND OF THE FORMULA:
Claim 2
Dependent Claim 5 words
A COMPOUND OF THE FORMULA:
Claim 3
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-ethyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 4
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-ethyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 5
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-n-propyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 6
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-n-propyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 7
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-methyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 8
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-methyl-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 9
Dependent Claim 9 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-carbethoxy-3-aza-pentamethylene) -acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 10
Dependent Claim 9 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-carbethoxy-3-aza-pentamethylene) -acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 11
Dependent Claim 9 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-isopropyl-3-aza-pentamethylene) -acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 12
Dependent Claim 9 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-isopropyl-3-aza-pentamethylene) -acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 13
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-(2-hydroxy-1-propyl)-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 14
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-(2-hydroxy-1-propyl)-3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 15
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.
Claim 16
Dependent Claim 8 words
2-(2-Ethyl-3-benzofuranyl)-N,N-(3-aza-pentamethylene)-acetamidine or its pharmaceutically acceptable acid addition salts.

References Cited (Backward Citations)

US3189614A Cited
US3282953A Cited
US3700697A Cited
US3697505A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-11-03 1979-05-05 1979-11-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-11-03 1983-05-05 1983-11-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-11-03 1987-05-05 1987-11-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag